Skip to main content
DFTX
NASDAQ Life Sciences

Definium's Psychedelic Drug DT120 Shows Strong Efficacy in Phase 3 Depression Trial, Shares Surge 50%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$35
Mkt Cap
$3.999B
52W Low
$6.345
52W High
$39.16
52W Position info
452% above low
Off High info
11% below high
Rel. Volume info
9.1× avg
Market data snapshot near publication time

DFTX has more than doubled off its 52-week low of $6.345 on elevated volume (9.1× avg).

Summary

Definium Therapeutics' psychedelic drug DT120 showed strong efficacy in its Phase 3 trial for depression, reducing symptoms by 8.1 points on a 60-point scale and sustaining the benefit for three months after a single dose. This WSJ report elaborates on earlier positive topline results announced today, which have already sent shares up 50%. These robust results for a late-stage psychedelic drug are a major de-risking event, exceeding analyst expectations and validating the company's pipeline. The company is now launching a $500 million public offering, likely to fund further development and commercialization efforts.

At the time of this announcement, DFTX was trading at $35.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4B. The 52-week trading range was $6.35 to $39.16. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

DFTX - Latest Insights

DFTX
Nov 09, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.00
Real-time Price: $31.78 info
Change: -$4.22 (-12%) info
Market Cap: $4.351B info
DFTX
Nov 09, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $35.36
Real-time Price: $31.78 info
Change: -$3.57 (-10%) info
Market Cap: $4.351B info
DFTX
Sep 14, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $45.00
Real-time Price: $31.78 info
Change: -$13.22 (-29%) info
Market Cap: $4.351B info
DFTX
Sep 14, 2026, 7:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $41.46
Real-time Price: $31.78 info
Change: -$9.68 (-23%) info
Market Cap: $4.351B info
DFTX
Sep 08, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $39.39
Real-time Price: $31.78 info
Change: -$7.61 (-19%) info
Market Cap: $4.351B info